Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Feb;111(2):570–574. doi: 10.1111/j.1476-5381.1994.tb14775.x

Characterization of the tachykinin NK2 receptor in the human bronchus: influence of amastatin-sensitive metabolic pathways.

M Astolfi 1, S Treggiari 1, A Giachetti 1, S Meini 1, C A Maggi 1, S Manzini 1
PMCID: PMC1909962  PMID: 8004400

Abstract

1. The aim of this study was to characterize the tachykinin NK2 receptor subtype mediating the spasmogenic response in the human isolated bronchus. The motor response to neurokinin A (NKA) and the selective NK2 agonist [beta Ala8]NKA(4-10), as well as the antagonistic effects of cyclic (L659,877) and linear (MEN 10376) peptide NK2 antagonists were assessed in the presence or absence of amastatin (an inhibitor of aminopeptidases A and M). 2. NKA was more potent than [beta Ala8]NKA(4-10) in eliciting bronchoconstriction (pD2 being 7,43 and 6,87 respectively). In the presence of amastatin (1 microM), the estimated affinity of [beta Ala8]NKA(4-10), but not that of NKA, was significantly increased to yield a pD2 of 7,44. 3. L659,877 and MEN 10376 inhibited [beta Ala8]NKA(4-10)-induced contraction with similar affinities; pA2 values were 5.7 +/- 0.22 and 6.3 +/- 0.32, respectively. Amastatin (1 microM) increased the potency of MEN 10376 to 7.28 +/- 0.46, whereas that of L659,877 was unaffected. 4. In the presence of amastatin the pseudopeptide MDL 28,564 behaved as a partial agonist. 5. We conclude that the NK2 receptor subtype present in the human bronchus has properties similar to those described for the circular muscle of the human colon and thus may be classified as a 'NK2A' subtype. We show that the apparent potency of peptides, bearing N-terminal acidic residues, is influenced by an amastatin-sensitive peptidase, possibly aminopeptidase A.

Full text

PDF
570

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Naline E., Drapeau G., Regoli D. Relative potencies of neurokinins in guinea pig trachea and human bronchus. Eur J Pharmacol. 1987 Jul 9;139(2):133–137. doi: 10.1016/0014-2999(87)90244-5. [DOI] [PubMed] [Google Scholar]
  2. Advenier C., Rouissi N., Nguyen Q. T., Emonds-Alt X., Breliere J. C., Neliat G., Naline E., Regoli D. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem Biophys Res Commun. 1992 May 15;184(3):1418–1424. doi: 10.1016/s0006-291x(05)80041-5. [DOI] [PubMed] [Google Scholar]
  3. Ahmad S., Ward P. E. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther. 1990 Feb;252(2):643–650. [PubMed] [Google Scholar]
  4. Cheung D., Bel E. H., Den Hartigh J., Dijkman J. H., Sterk P. J. The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis. 1992 Jun;145(6):1275–1280. doi: 10.1164/ajrccm/145.6.1275. [DOI] [PubMed] [Google Scholar]
  5. Devillier P., Advenier C., Drapeau G., Marsac J., Regoli D. Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea. Br J Pharmacol. 1988 Jul;94(3):675–684. doi: 10.1111/j.1476-5381.1988.tb11575.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dion S., Rouissi N., Nantel F., Drapeau G., Regoli D., Naline E., Advenier C. Receptors for neurokinins in human bronchus and urinary bladder are of the NK-2 type. Eur J Pharmacol. 1990 Mar 20;178(2):215–219. doi: 10.1016/0014-2999(90)90477-n. [DOI] [PubMed] [Google Scholar]
  7. Dion S., Rouissi N., Nantel F., Jukic D., Rhaleb N. E., Tousignant C., Télémaque S., Drapeau G., Regoli D., Naline E. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor. Pharmacology. 1990;41(4):184–194. doi: 10.1159/000138717. [DOI] [PubMed] [Google Scholar]
  8. Giuliani S., Barbanti G., Turini D., Quartara L., Rovero P., Giachetti A., Maggi C. A. NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype. Eur J Pharmacol. 1991 Oct 22;203(3):365–370. doi: 10.1016/0014-2999(91)90892-t. [DOI] [PubMed] [Google Scholar]
  9. Honda I., Kohrogi H., Yamaguchi T., Ando M., Araki S. Enkephalinase inhibitor potentiates substance P- and capsaicin-induced bronchial smooth muscle contractions in humans. Am Rev Respir Dis. 1991 Jun;143(6):1416–1418. doi: 10.1164/ajrccm/143.6.1416. [DOI] [PubMed] [Google Scholar]
  10. Ireland S. J., Bailey F., Cook A., Hagan R. M., Jordan C. C., Stephens-Smith M. L. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol. 1991 Jun;103(2):1463–1469. doi: 10.1111/j.1476-5381.1991.tb09812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Komatsu T., Yamamoto M., Shimokata K., Nagura H. Distribution of substance P-immunoreactive and calcitonin gene-related peptide-immunoreactive nerves in normal human lungs. Int Arch Allergy Appl Immunol. 1991;95(1):23–28. doi: 10.1159/000235449. [DOI] [PubMed] [Google Scholar]
  12. Lundberg J. M., Hökfelt T., Martling C. R., Saria A., Cuello C. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res. 1984;235(2):251–261. doi: 10.1007/BF00217848. [DOI] [PubMed] [Google Scholar]
  13. Maggi C. A., Giuliani S., Patacchini R., Santicioli P., Theodorsson E., Barbanti G., Turini D., Giachetti A. Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors. Gastroenterology. 1992 Jan;102(1):88–96. doi: 10.1016/0016-5085(92)91787-5. [DOI] [PubMed] [Google Scholar]
  14. Martling C. R., Theodorsson-Norheim E., Lundberg J. M. Occurrence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways. Life Sci. 1987 Apr 20;40(16):1633–1643. doi: 10.1016/0024-3205(87)90130-5. [DOI] [PubMed] [Google Scholar]
  15. Naline E., Devillier P., Drapeau G., Toty L., Bakdach H., Regoli D., Advenier C. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis. 1989 Sep;140(3):679–686. doi: 10.1164/ajrccm/140.3.679. [DOI] [PubMed] [Google Scholar]
  16. Parlani M., Conte B., Majmone S., Maggi C. A., Rovero P., Giachetti A. The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors. J Urol. 1990 Dec;144(6):1543–1545. doi: 10.1016/s0022-5347(17)39795-1. [DOI] [PubMed] [Google Scholar]
  17. Patacchini R., Astolfi M., Quartara L., Rovero P., Giachetti A., Maggi C. A. Further evidence for the existence of NK2 tachykinin receptor subtypes. Br J Pharmacol. 1991 Sep;104(1):91–96. doi: 10.1111/j.1476-5381.1991.tb12390.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Patacchini R., Maggi C. A. Amastatin interferes with the antagonist properties of MEN 10,208 in the rabbit pulmonary artery but not in the hamster trachea. Eur J Pharmacol. 1993 May 12;236(1):31–37. doi: 10.1016/0014-2999(93)90223-5. [DOI] [PubMed] [Google Scholar]
  19. Patacchini R., Maggi C. A., Rovero P., Regoli D., Drapeau G., Meli A. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens. J Pharmacol Exp Ther. 1989 Aug;250(2):678–681. [PubMed] [Google Scholar]
  20. Rich D. H., Moon B. J., Harbeson S. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. J Med Chem. 1984 Apr;27(4):417–422. doi: 10.1021/jm00370a001. [DOI] [PubMed] [Google Scholar]
  21. Rogers D. F., Aursudkij B., Barnes P. J. Effects of tachykinins on mucus secretion in human bronchi in vitro. Eur J Pharmacol. 1989 Dec 19;174(2-3):283–286. doi: 10.1016/0014-2999(89)90322-1. [DOI] [PubMed] [Google Scholar]
  22. Wang L. H., Ahmad S., Benter I. F., Chow A., Mizutani S., Ward P. E. Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides. 1991 Nov-Dec;12(6):1357–1364. doi: 10.1016/0196-9781(91)90220-j. [DOI] [PubMed] [Google Scholar]
  23. van Giersbergen P. L., Shatzer S. A., Harbeson S. L., Rouissi N., Nantel F., Buck S. H. Multiple NK2 receptor subtypes are suggested by physiological and biochemical studies with neurokinin A (NKA) analogues and antagonists. Ann N Y Acad Sci. 1991;632:483–484. doi: 10.1111/j.1749-6632.1991.tb33164.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES